Bharat Biotech
-
Ocugen ties up with Bharat Biotech for COVAXIN in Canada
Ocugen will make an upfront payment and milestone payment upon first commercial sale in Canada to Bharat Biotech Biopharmaceutical company…
Read More » -
Serum Institute, Bharat Biotech to ramp up vaccine production
Serum said it would ramp production to 10 crore by August, while Bharat Biotech promised 7.8 crore monthly production With…
Read More » -
Bharat Biotech demonstrates 100% efficacy against severe COVID-19 disease
Safety and efficacy results from the final analysis will be available in June, and the final report will be submitted…
Read More » -
Bharat Biotech announces COVAXIN capacity expansion
The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach ~ 700 million doses /…
Read More » -
Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year
The Mumbai-based company said that it will take least at one year time for the company to start actual production…
Read More » -
Brazil’s health regulator rejects Covaxin import
According to the Brazilian authorities, the vaccine manufacturing plant did not meet good practice requirements Brazil’s health regulator Anvisa has…
Read More » -
India seeks funds from Quad alliance to match China’s vaccine push: Source
India has urged the US, Japan and Australia to invest in its vaccine production capacity India has urged the US,…
Read More » -
Delhi HC directs covid vaccine providers to disclose manufacturing capacities
The Centre has been asked to explain in an affidavit the rationale behind keeping strict control over the class of…
Read More » -
Bharat Biotech Phase 3 COVAXIN trials show 81 per cent efficacy
Data from 25,800 participants, received vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well tolerated…
Read More » -
Ocugen in agreement with Bharat Biotech
Ocugen to receive an initial supply of COVAXIN doses from Bharat Biotech upon authorization from US regulatory authorities while it…
Read More »
